Black women with early hormone receptor-positive breast cancer experienced shorter relapse-free intervals and overall survival compared with white women, according to findings published in JAMA Oncology.
Pregnant and postpartum individuals infected with SARS-CoV-2 during pregnancy have an increased risk of maternal mortality or morbidity from obstetric complications, according to a recent study.
Treating breast tumors alongside distant metastases did not improve outcomes in women with stage IV breast cancer, according to a new study.
A new study shines a spotlight on an important but often overlooked matter of the heart — optimizing cardiovascular health before getting pregnant.
A new study suggests that one contributor to inequities in pregnancy and cardiovascular outcomes may be the stress created by police violence occurring in Black women’s neighborhoods.
Neural stem cells engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
Circulating tumor cells use the surface protein ICAM1 to strengthen stem cell programs and facilitate formation of tumor cell clusters, which can travel from primary tumors to other organs in the body.
Women with early, nonviable pregnancies of unknown location who were given an active management strategy had more successful pregnancy resolutions than those given an expectant management strategy, according to a randomized clinical trial published in JAMA.
The rate of gestational diabetes has shot up 30 percent in young U.S. women over the past decade according to a new Northwestern Medicine study.
Blessing Aghaulor, MD, MPH, a former resident in internal medicine and current fellow in Gastroenterology and Hepatology, has conducted research on transplant outcomes and consulted about patients at the ERASE trafficking clinic in Chicago.